Decision Rights in Matrixed Clinical Trial Teams

Clinical trial teams are matrixed by design. The study lead coordinates contributors from medical, regulatory, biostatistics, data management, safety, and supply chain, none of whom report to them. This structure is sensible. It is also the source of most avoidable delay in clinical execution.

The delay rarely comes from disagreement. It comes from ambiguity about who decides. A question about whether a particular data discrepancy requires a query or a protocol deviation report circulates for eleven days, touching four functions, because nobody is certain the decision belongs to them and everybody is certain it might belong to someone else. The eventual answer takes four minutes to reach once the right person looks at it.

The fix is unglamorous. Write down the decision rights.

For a clinical study team, the categories worth defining explicitly include protocol interpretation questions from sites, eligibility waivers, protocol deviation classification, vendor scope changes below a threshold, communication to sites, safety reporting judgments, and timeline commitments to governance. For each, name who decides, who must be consulted first, and who is informed after. A single page covers most of it.

Leaders often resist this as bureaucratic. The resistance misreads the cost. Ambiguous decision rights do not produce flexibility; they produce escalation, and escalation produces senior leaders spending their time on questions well below their pay grade while the genuinely hard questions wait.

There is a second benefit that matters for leadership development. Explicit decision rights make it possible to delegate authority in visible, incremental steps. A clinical trial manager can be given decision authority over deviation classification this quarter and vendor scope changes under a defined threshold next quarter. That progression is trackable, discussable in a development conversation, and far more meaningful than a training curriculum.

Teams that operate with clear decision rights move faster and escalate better, because when something genuinely does need senior attention, everyone recognizes it immediately. Teams without them escalate constantly and therefore escalate nothing effectively.